SBIR-STTR Award

DNA probe amplification for detecting oral bacteria
Award last edited on: 2/28/02

Sponsored Program
SBIR
Awarding Agency
NIH : NIDCR
Total Award Amount
$48,800
Award Phase
1
Solicitation Topic Code
-----

Principal Investigator
Robert W Kwiatkowski

Company Information

OmniGene Inc (AKA: OmniGene Bioproducts Inc)

763 D Concord Avenue
Cambridge, MA 02138
Location: Single
Congr. District: 05
County: Middlesex

Phase I

Contract Number: 1R43DE009901-01A2
Start Date: 00/00/00    Completed: 00/00/00
Phase I year
1992
Phase I Amount
$48,800
Enumeration of prominent oral bacteria to aid in assessing caries and periodontal diseases requires a reliable, quantitative, sensitive and specific diagnostic test. Nucleic acid probes provide a reliable and specific diagnostic tool, but may require signal amplification for the necessary sensitivity. We have developed a unique amplification system called Ligase Chain Reaction (LCR) whose performance compares favorably with other available amplification methods, such as Polymerase Chain Reaction (PCR). The feasibility of using LCR amplification protocols to detect oral bacteria has been demonstrated using a cloned DNA probe which was previously identified, and shown to be specific for Actinobacillus actinomycetemcomitans. In Phase I, species-specific DNA probes will be identified for six supraginigival organisms. The use of LCR amplification requires well-characterized and specific oligonucleotide probes. In Phase I, whole genomic DNA will be isolated from the six target strains and DNA libraries of each constructed. The cross-reactivity between the target species and other oral bacteria will be determined using chromosomal DNA as probes. The identification of the most cross-reactive species will enable an efficient screening protocol to be designed for screening the libraries in order to isolate cloned species-specific probes. In Phase II, the cloned probes isolated in Phase I will be sequenced, appropriate diagnostic target regions identified, and LCR probe sets synthesized. The probe sets will be tested in the LCR format and reaction conditions defined in order to maximize the specificity and sensitivity of the system. This will include designing a sample preparation protocol which provides DNA with sufficient purity to permit LCR amplification and implementing a non-isotopic read-out format for handling multiple samples in a short time. Finally, field testing required for regulatory review would be initiated.Awardee's statement of the potential commercial applications of the research:A reliable diagnostic test with a high degree of specificity and sensitivity would be useful in two general areas: (1) in assessing caries risk, periodontal health and disease risk and (2) in performing clinical trials designed to evaluate oral hygiene products with antiplaque claims currently available and under development.National Institute of Dental Research (NIDR)

Phase II

Contract Number: ----------
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
----
Phase II Amount
----